Register for streaming realtime charts, analysis tools, and prices.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Relmada Therapeutics Inc (RLMD)
Relmada Therapeutics Inc (RLMD) Financials

RLMD Relmada Therapeutics Inc

3.17

-0.07 (-2.16%)

Last Updated: 15:25:56

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End December 30 2023	2017	2018	2019	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Return on Assets (%)	-443.215	-304.537	-261.049	-13.641	-92.606	-73.644	-83.483	-78.889
Return on Equity (%)	-861.233	442.191	-1649.333	-14.881	-105.05	-80.136	-90.074	-87.507
Return on Invested Capital (%)	-1312.545	293.653	-1617.281	-15.084	-107.816	-80.141	-92.502	-91.888
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	0.117	-0.439	0.195	8.002	6.464	7.508	4.666	2.836
Earnings Per Share	-0.502	-0.714	-0.444	-0.567	-3.64	-4.533	-5.218	-3.282
Cash Per Share	0.137	0.178	0.236	2.509	0.153	1.602	0.179	0.136
Working Capital Per Share	0.088	-0.252	0.189	7.988	6.458	7.507	4.665	2.834
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	-0.502	-0.714	-0.444	-0.567	-3.64	-4.533	-5.218	-3.282
EBITDA Per Share	-0.502	-0.714	-0.444	-0.567	-3.64	-4.533	-5.218	-3.282
Free Cash Flow Per Share	-0.498	-0.713	-0.444	-0.567	-3.64	-4.533	-5.218	-3.282

Liquidity Ratios

Year End December 30 2023	2017	2018	2019	2019	2020	2021	2022	2023
Current Ratio	1.797	0.464	3.83	80.206	9.369	14.826	12.26	7.996
Quick Ratio	1.243	0.379	3.535	79.866	9.291	14.07	11.895	7.899
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	12.53M	12.55M	38.98M	14.46M	16.33M	27.74M	30.1M	N/A

Key Stats and Ratios

Year End December 30 2023	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Shares Outstanding	29.4M	30.03M	28.64M	30.1M	N/A	N/A	30.1M	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	14.652	N/A	N/A	N/A	13.423	N/A	N/A	N/A
Quick Ratio	14.319	N/A	N/A	N/A	13.117	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	96.02M
Price to Earnings Ratio	-0.97
Price to Sales Ratio	0
Price to Cash Ratio	23.46
Price to Book Ratio	1.12
Dividend Yield	-

Share Statistics

Shares Outstanding	30.1M
Average Volume (1 week)	64.28k
Average Volume (1 Month)	87.45k
52 Week Change	-0.31%
52 Week High	7.2225
52 Week Low	2.3601

More Ratios Coming Soon!

Relmada Therapeutics

Summit Financial

Delayed Upgrade Clock